By employing a panel dataset of Chinese listed companies spanning from 2010 to 2021, our study empirically examines the correlation between corporate financialization and corporate green innovation, and explores its heterogeneities in terms of property rights structure and digitalization. Our...

This study investigates how enhanced regulation can promote innovation, focusing on the impacts of a significant regulatory reform in China's pharmaceutical sector implemented in 2015. Inspired by regulatory practices in the U.S., the reform aimed to address application backlogs and reduce...